Canada Pension Plan Investment Board’s Pacific Biosciences PACB Stock Holding History

Canada Pension Plan Investment Board’s Portfolio PACB Stock Details PACB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$142K	Buy	+107,800	New	+$193K	﹤0.01%	1620
2025 Q4	–	Sell	-61,900	Closed	-$79.2K	–	2011
2025 Q3	$79.2K	Sell	61,900 -11,400	-16%	-$15.4K	﹤0.01%	1216
2025 Q2	$90.9K	Buy	73,300 +66,800	+1,028%	+$77.1K	﹤0.01%	1196
2025 Q1	$7.67K	Hold	6,500	–	–	﹤0.01%	1278
2024 Q4	$11.9K	Sell	6,500 -25,600	-80%	-$50K	﹤0.01%	1371
2024 Q3	$54.6K	Sell	32,100 -35,500	-53%	-$58.3K	﹤0.01%	1230
2024 Q2	$92.6K	Buy	+67,600	New	+$137K	﹤0.01%	1195
2021 Q2	–	Sell	-184,000	Closed	-$6.13M	–	1300
2021 Q1	$6.13M	Buy	+184,000	New	+$6.44M	0.01%	602
2020 Q1	–	Sell	-282,500	Closed	-$1.45M	–	1429
2019 Q4	$1.45M	Hold	282,500	–	–	﹤0.01%	936
2019 Q3	$1.46M	Sell	282,500 -144,900	-34%	-$810K	﹤0.01%	898
2019 Q2	$2.59M	Sell	427,400 -88,500	-17%	-$621K	0.01%	899
2019 Q1	$3.73M	Sell	515,900 -841,300	-62%	-$6.08M	0.01%	865
2018 Q4	$10M	Buy	+1,357,200	New	+$8.6M	0.02%	566

Other funds holding PACB

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Canada Pension Plan Investment Board's PACB Position: Q1 2026 in Review

Canada Pension Plan Investment Board opened a new position in Pacific Biosciences (PACB) in Q1 2026: 107,800 shares worth $142K. The stake represents ﹤0.01% of the portfolio and ranks #1620 among its holdings. This is a return to the name: Canada Pension Plan Investment Board previously reported a position in PACB as recently as Q3 2025.

Canada Pension Plan Investment Board first reported a position in PACB in Q4 2018 and has held it in 13 quarters since. The position peaked at $10M in Q4 2018. 229 funds tracked by Wall St. Rank hold PACB as of Q1 2026.

Canada Pension Plan Investment Board held 107,800 shares of Pacific Biosciences worth $142K as of Q1 2026.
Pacific Biosciences was a new Canada Pension Plan Investment Board position in Q1 2026.
Pacific Biosciences made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q1 2026, its #1620 holding.
Canada Pension Plan Investment Board first reported a position in Pacific Biosciences in Q4 2018 and has held it in 13 quarters since.
Canada Pension Plan Investment Board's Pacific Biosciences position peaked at $10M in Q4 2018.
229 funds tracked by Wall St. Rank held Pacific Biosciences as of Q1 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q1 2026, filed 15 May 2026.